首页> 中文期刊>中国继续医学教育 >支气管哮喘急性发作期血清C反应蛋白检验的临床分析

支气管哮喘急性发作期血清C反应蛋白检验的临床分析

     

摘要

Objective To investigate the effect of serum C reactive protein test in the acute stage of bronchial asthma. Methods 42 patients with bronchial asthma in our hospital from January to September 2016 were chosen as the study group, the control group was treated with 42 healthy persons as the study group. In the two groups, the serum C reactive protein test was carried out, and the changes of serum C reactive protein level were analyzed.Results The levels of C reactive protein in the study group and the control group were (46.4±11.2) mg/L,(3.4±1.2) mg/L, and the difference was signiifcant (P<0.05). In mild group, moderate group and severe group, the serum levels of C reactive protein were signiifcantly different (P<0.05) before and after treatment. Conclusion The test of serum C reaction protein can be used as an important indicator to determine the acute stage of bronchial asthma.%目的:探讨血清C反应蛋白检验在支气管哮喘急性发作期的应用效果。方法以2016年1~9月本院收治的42例支气管哮喘急性发作期患者为研究组,以同期到本院体检的42例健康人为对照组。两组患者均实施血清C反应蛋白检验,分析其血清C反应蛋白水平变化。结果研究组、对照组血清C反应蛋白水平分别为(46.4±11.2)mg/L、(3.4±1.2)mg/L,差异有统计学意义(P<0.05);轻度组、中度组、重度组治疗前后血清C反应蛋白水平均差异有统计学意义(P<0.05)。结论血清C反应蛋白检验可作为判断支气管哮喘急性发作期的重要指标应用于临床。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号